Elsevier,
Clinical Breast Cancer, Volume 22, June 2022
This study explores the current status and problems of breast cancer treatment with schizophrenia, including advanced stage diagnosis. It finds that patients with schizophrenia with reduced ADL are less likely to receive chemotherapy or recommended cancer treatment, and as such it is highly recommended that they breast cancer screening so that they can be diagnosed early and treated adequately.
Elsevier,
IBRO Neuroscience Reports, Volume 12, June 2022
This review attempts to shed more light on the prevalence of depression in Sub-Saharan Africa (SSA), its pathophysiology, risk factors, diagnosis and the experimental models available to study depression within the sub-region. It also evaluates the contribution of the sub-region to the global research output of depression as well as bottlenecks associated with full exploitation of the sub region’s resources to manage the disorder.
Elsevier,
IBRO Neuroscience Reports, Volume 12, June 2022
Financial constraints usually hinder students, especially those in low-middle income countries (LMICs), from seeking mental health interventions. Hence, it is necessary to identify effective, affordable and sustainable counter-stress measures for college students in the LMICs context. This study examines the sustained effects of mindfulness practice on the psychological outcomes and brain activity of students.
Elsevier,
SLAS Discovery, Volume 27, June 2022
Understanding the pathogenesis that leads to carcinogenesis of HIV-related gastrointestinal KS is essential for the treatment of diseases related to KSHV infection. This study strived to evaluate the effect of miR-K12–1 on the progression of HIV-related gastrointestinal KS.
